Matsuura, E.; Nozuma, S.; Dozono, M.; Kodama, D.; Tanaka, M.; Kubota, R.; Takashima, H.
Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Pathogens 2023, 12, 592.
https://doi.org/10.3390/pathogens12040592
AMA Style
Matsuura E, Nozuma S, Dozono M, Kodama D, Tanaka M, Kubota R, Takashima H.
Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Pathogens. 2023; 12(4):592.
https://doi.org/10.3390/pathogens12040592
Chicago/Turabian Style
Matsuura, Eiji, Satoshi Nozuma, Mika Dozono, Daisuke Kodama, Masakazu Tanaka, Ryuji Kubota, and Hiroshi Takashima.
2023. "Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)" Pathogens 12, no. 4: 592.
https://doi.org/10.3390/pathogens12040592
APA Style
Matsuura, E., Nozuma, S., Dozono, M., Kodama, D., Tanaka, M., Kubota, R., & Takashima, H.
(2023). Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Pathogens, 12(4), 592.
https://doi.org/10.3390/pathogens12040592